Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

DOI10.1038/NBT.3437MaRDI QIDQ68752WikidataFDO

Authors John G Doench, Nicolo Fusi, Meagan E Sullender, Mudra Hegde, Emma W Vaimberg, Katherine F Donovan, Ian Smith, Zuzana Tothova, Craig Wilen, Robert Orchard, Herbert W Virgin, Jennifer Listgarten, David E Root

Publication date 18 January 2016

Published in Nature Biotechnology (Search for Journal in Brave)

Cited in

(1)

• crispRdesignR

This page was built for publication: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q68752)